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Information regarding the chimeric status of hemato-
poietic stem cell transplantation (HSCT) recipients is of
great significance when comparing different conditioning
and prophylactic therapies. In recent years, short tandem
repeats/variable number tandem repeats (STRs/VNTRs)
have emerged as the best tool for chimerism monitoring.
However, the polymorphisms of STR/VNTR markers
vary within and between ethnic groups. The issue is further
complicated in a heterogeneous population such as occurs
in the Indian subcontinent. In the present study, we
attempted to devise a robust scheme to identify a set of
polymorphic STRs/VNTRs most suitable for chimerism
evaluation in north Indian HCST recipients. At first, we
did genotyping of 11 STR and one VNTR in 1000
randomly chosen north Indian individuals to quantify
different diversity parameters. Resulting data indicated
that ApoB30HVR, FES, VWA, D3S1358 and D16S310
were most polymorphic loci with the average heterozygo-
sity being 0.75670.17. Furthermore, all markers were
genotyped in 77 HLA-matched donor–recipient pairs to
evaluate the informativeness in differentiating donor’s and
recipient’s cells. A panel of seven markers (ApoB3HVR-
D3S1358-HUM-THO1-VWF-1-D16S310-FES-VWA)
differentiated 98.70% of donor–recipient pairs. This set of
markers also successfully monitored the graft status in 14
HSCT cases during multiple time points following HSCT.
The results were compared to the commercially available
AmpF/STR SGM Plus multiplex PCR kit (Applied
Biosystems, Foster City, CA, USA). Our findings
established that the panel of seven markers we identified
was more cost-effective and informative.
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Introduction
Quantification and assessment of the pattern and distribu-
tion of genetic variation among different human popula-
tions is an essential step targeted in the Human Genome
diversity program.1 It was established that humans are
considerably more similar to each other than other species,
as any two randomly chosen humans differ at B1 in 1000
nucleotide pairs.2 However, there are B3 billion nucleo-
tides on the human haploid genome and therefore any two
randomly chosen humans differ at B3 million nucleotides
that constitutesB0.1–0.2% of the total genome.3 This tiny
genomic fraction leads to the disparity in human suscept-
ibility to diseases and differential human response to
pharmacological agents and produces varied phenotypes.
The same fraction of genetic variation is also used for a
range of applications including ‘chimerism’-based graft
monitoring following hematopoietic stem cell transplant-
ation (HSCT).4
Allogeneic HSCT is considered to be the best treatment
modality for various malignant and non-malignant hema-
tological disorders. In human HSCT, complete donor-
derived hematopoiesis is considered essential for sustained
engraftment and for preventing relapse of the underlying
disease.5 The critical task following HSCT is the qualitative
and quantitative examination of the donor-specific cells in
the recipient’s body. Such analysis is based on chimerism
monitoring that varies from exclusively autologous cells to
mixed (both autologous and donor cells) and complete
chimerism (only donor cells). Chimerism monitoring has
therefore become essential for identifying/predicting the
success or failure of HSCT.6
The underlying principle of chimerism monitoring is
differentiation of donor and recipient cells based on their
genetic constitution. The genotypic profile of polymorphic
genetic markers or those of their products in recipient and
donor act as a specific tag to identify and quantify the
presence of specific cell types in the post HSCT recipient.
However, the key task would be in identifying the
markers that have maximum chances of being informative
(i.e. having a different genotype in donor and recipient).
In the recent years, various methods including erythrocyte
phenotyping,7 RFLP8 and fluorescence in situ hybri-
dization9 and quantitative real-time PCR10 have been used
to establish chimerism status. Fluorescent primer-based
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PCR genotyping of highly polymorphic STRs/VNTRs is
widely regarded as the most successful and robust
genotyping technique,11 largely because of the uniform
repeat lengths and high degree of polymorphism of
STR/VNTR markers with high sensitivity and quantifica-
tion ability.
In the present study, we set out to develop a cost-effective
and robust scheme for chimerism analysis for north Indian
HCT patients based on the identification of a set of highly
informative markers. Currently, more than 15 transplant
centers carry out stem cell transplants in India and have
used this potentially curative mode of therapy in upwards
of 800 patients. Therefore, more dedicated efforts are
required to identify a panel of markers that possess
maximum probability of genetically differentiating HLA-
matched donor/recipient pairs. The study requires more
consideration in the Indian population, due in part to the
high level of socio-cultural and geographical diversity often
creating varied gene pools. The characteristic of genetic
heterogeneity led to the screening of a significant number of
markers culminating in an informative panel for chimerism
evaluation.
We have designed our search directive towards an
effective set of markers based on three criteria: the level
of genetic diversity within randomly selected individuals,
the informativeness of the markers in donor–recipient pairs
and the success rate in graft monitoring. To meet each of
these criteria, we analyzed a set of 11 markers (10 STR and
one VNTR) in three groups: (i) 1000 randomly selected
samples of varied socio-religious groups of north India by
determining the allelic variability for each marker; (ii) 77
pairs of HLA-matched HSCT donor/recipient pairs by
assessing the informativeness of each marker and (iii) we
analyzed the identified set of most informative markers in
14 HSCT patients at different time periods following HSCT
by assessing their success in monitoring different engraft-
ment status. The findings were then compared with that of
a commercially available kit to evaluate the cost-effective-
ness of the identified set of markers.
Materials and methods
Subjects
To meet our objective, this study included 1077 subjects
(1000 randomly selected north Indian individuals and 77
HSCT donor–recipient pairs, matched at all five HLA
class I and II loci including those 14 patients that were
transplanted at SGPGIMS, Lucknow since July 2000).
Whole blood specimens were obtained from all the study
subjects by peripheral venipuncture and approximately 5ml
of blood was collected in EDTA vacutainer tubes after
obtaining informed consent from each subject. The study
was performed following approval by the Institutional
Ethical Reviewing Committee of Sanjay Gandhi Post
Graduate Institute of Medical Sciences (SGPGIMS),
Lucknow.
Random north Indian samples. A total of 1000 randomly
selected individuals belonging to different socio-cultural
strata were collected from different regions of the northern
state (Uttar Pradesh) of India. All individuals were adult
with a mean age of 38.873.4 years and resident in Uttar
Pradesh for the last three generations. Before collecting the
blood specimens, regional addresses and detailed compu-
terized list of the subjects were prepared. Random numbers
were generated by computer and adults were questioned
regarding their ethnicity and the birthplace of their parents.
Unrelated subjects were considered eligible for participa-
tion in the study. The demographic profile and other
ethnical and familial information were recorded in a
detailed Performa. Three-generation pedigrees were pre-
pared to assure non-related status of subjects.
HLA-matched HSCT donor–recipient pairs. A total of 167
families were registered with the Department of Hemat-
ology, SGPGIMS for HSCT from 1996 to 2006. Families
of each patient were referred to the Department of Medical
Genetics for HLA class I and II matching. Donors were
identified for 77 patients based on complete matching at
five HLA loci–class I (A, B and C) and class II (DRB1 and
DQB1).
Patient treated with HSCT. A total of 14 patients
transplanted with non-myeloablative regimens since July
2000 were analyzed for chimerism-based graft monitoring
at different time intervals following HSCT. The graft
monitoring was performed on the 14th day following
transplantation, then by weekly intervals until 1 month and
then every month for next 6 months, if complete chimerism
was achieved. Six months post transplant, we began
following the patients at 3-month intervals, provided
complete chimerism persisted. In case of recipients with
mixed chimerism, weekly chimerism evaluation was pre-
ferred.
DNA extraction
High molecular weight genomic DNA was extracted
through a salting out method using phenol–chloroform
and purified by ethanol precipitation.12
STR/VNTR genotyping
Genotyping methodology. A panel of 10 STR markers
(Tho1, D3S1358, D16S310, F13A, TPO, FES, VWA,
D4S243, DHFRP2 and VWF-1) and one VNTR (ApoB-
30HVR) were genotyped as described previously13 using
PCR-based locus-specific amplification. One primer for
each marker was labeled with a fluorochrome–VIC
(D4S243, VWA, D16S310), Ned (TPO, FES, DHFRP2)
and 6-FAM (D3S1358, Tho1, F13A1, VWF-1 and ApoB).
Six STR markers were co-amplified by two multiplex PCR.
The remaining four STR and ApoB3HVR were amplified
using flanking primers in a single PCR reaction. Size
fractionation of the fluorochrome labeled amplicons was
carried out by capillary electrophoresis in an ABI-310
PRISM fragment analyzer (Applied Biosystems, Foster
City, CA, USA). Size calling of the alleles at individual
locus was performed with GENESCAN v3.1.2 software
using 500-ROX and 1000-ROX (ABI, USA) size standard.
Once the size calling was completed, GENOTYPER v2.5.2
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software was employed for assigning the allelic profile of an
individual for each marker.
Statistical analysis
Allele frequencies were obtained through a direct counting
method. Hardy–Weinberg equilibrium at genotypic fre-
quencies for all markers was estimated using Fischer’s exact
test based on 1000 Markov-Chain algorithm steps with
Arlequin v2 software. Bonferroni correction to the P-value
was applied. Genetic diversity parameters like gene
diversity, observed heterozygosity, polymorphism informa-
tion content (PIC), power of exclusion (PE) and mean
numbers of pair wise differences were estimated using
the following software: Pop Gene v16, Cervus v2 and
Arlequin v2.
Results
Analysis of 11 repeat loci in randomly selected north Indian
individuals
Analysis of a panel of 11 autosomal repeat loci in 1000
randomly selected north Indian individuals has revealed
high allelic variability and level of genetic diversity. A total
of 111 alleles were observed that ranged from seven to nine
at seven STR loci (Tho1, TPO, FES, VWA, D4S243,
DHFRP2 and VWF-1) whereas X11 alleles11–15 were
observed at the remaining three STR loci (D3S1358,
D16S310 and F13A). In contrast, 16 alleles were observed
only at ApoB03HVR (Table 1). The average number of
observed alleles was 10.09 and none of the 11 repeat loci
exhibited significant departures form HWE values.
In order to categorize the individual marker or a set
of markers for maximum individual identification
potential, different parameters like average gene diversity,
average observed heterozygosity, mean number of pair wise
differences, PIC and PE were calculated (Table 1). The
mean average gene diversity was found to be as high as
0.78170.188. Individually, maximum average gene diver-
sity was observed at ApoB-30HVR (85%), followed by
D3S1358 (84%), D16S310 (83%) and VWA (81%). The
average observed heterozygosity (Ho) was found to be
0.75670.17. Locus wise average observed heterozygosity
ranged between 0.835 at ApoB-30HVR to 0.675 at F13A.
A high value of mean number pair wise differences
(9.4673.67) was also observed. PIC was calculated to
determine the extent of polymorphism at each locus. It was
observed that PIC varied from 0.646 at TPO to 0.840 at
ApoB-30HVR. The mean PIC value of the 11 repeat loci
was found to be 0.758 suggesting high prospective of the
analyzed set of markers in chimerism analysis. The PE was
also calculated as an index of individualization potential of
a set of markers. A high value of total PE (0.99915) was
observed where ApoB-30HVR (0.545) and D3S1358 (0.522)
showed the maximum PE whereas TPO (0.283) showed
the least.
Analysis of 11 repeat loci in 77 HLA-matched HSCT
donor–recipient pairs
The 77 donor–recipient pairs matched at all five HLA class
I and class II loci were genotyped for the same panel of 11
markers to identify the most informative marker (that has a
different genotype in donor and recipient). The informa-
tiveness analysis revealed that individually, FES was most
informative (56%) closely followed by ApoB30HVR (54%)
and VWF1 (52%) as shown in Table 2. Average informa-
tiveness over all 11 STR loci was 46.27%; however, total
informativeness of all 11 STR loci, if analyzed together
was 100%.
Furthermore, we calculated the percentage of informa-
tiveness for different combinations of STR/VNTR markers
(Table 2). A group of markers was considered informative
Table 1 Locus wise values of genetic diversity indices evaluated among north Indian populations based on 11 STR/VNTR loci
Locus Genetic diversity indices
Expected heterozygosity Observed heterozygosity PIC Power of exclusion
THO1 0.785 0.765 0.765 0.417
D3S1358 0.840 0.807 0.824 0.522
D16S310 0.830 0.774 0.807 0.487
F13A 0.735 0.675 0.748 0.397
TPO 0.710 0.715 0.646 0.283
FES 0.788 0.775 0.772 0.438
VWA 0.810 0.795 0.783 0.447
D4S243 0.711 0.731 0.666 0.306
DHFRP2 0.746 0.699 0.742 0.390
VWF-1 0.782 0.752 0.725 0.406
ApoB30HVR 0.850 0.835 0.840 0.545
Genetic diversity indices
Total number of alleles 111
Average gene diversity 0.78270.188
Average observed heterozygosity 0.75670.170
Mean number of pair wise differences 9.46073.670
Mean polymorphism information content 0.758
Total power of exclusion 0.999915
Abbreviations: PIC¼ polymorphism information content; STR/VNTR¼ short tandem repeats/variable number tandem repeats.
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if any marker of that group was found to be informative
in a donor–recipient pair. Significantly, average infor-
mativeness revealed average number of donor–recipient
pairs for which a particular group of markers was
informative. The 3 STR group comprising ApoB30HVR,
FES and VWF1 exhibited maximum informativeness
(92.2%). In comparison, the group of D3S1358, D16S310
and DHFRP2 was least informative (79.2%). The five
STR group consisting of ApoB30HVR, FES, D3S1358,
VWA and D16S310 was informative for 96.10% of
donor–recipient pairs. The group of seven markers
carrying ApoB30HVR, D3S1358, VWF1, FES, VWA,
Tho1 and D16S310 enhanced the informativeness index
to 98.70%. This panel of seven markers (six STR and one
VNTR) was considered to be the most effective set for
chimerism monitoring. No further elevation in the in-
formativeness index was observed when an additional pair
of markers was included. In addition, the combination of
four and six loci did not reveal significant changes in
informativeness when compared to the set of three or five
loci, respectively.
Analysis of the panel of seven STR in 14 HSCT cases
The selected panel of the most informative seven markers
(ApoB30HVR, D3S1358, VWF1, FES, VWA, Tho1
and D16S310) was then used for graft monitoring in 14
recipients following HSCT. The graft monitoring was
performed at varying intervals beginning at the 14th
day after transplant. The identified panel of seven markers
was 100% successful in differentiating donor’s cells
from those of the recipient during all the stages after
engraftment.
Among those 14 HSCT cases transplanted at SGPGIMS,
we identified three different chimeric stages: complete
chimerism, mixed chimerism and only recipient cells in
the span of 3 years. We also observed that four markers
each (in the set of seven markers) were informative in eight
donor–recipient pairs, whereas five and six markers,
respectively, were informative in three pairs each.
Discussion
The search for a HLA compatible donor to facilitate a
successful HSCT has been the major area of concern for the
transplantation geneticists in the last few decades. How-
ever, in the recent years efforts have been made to identify
an ideal chimerism study tool, which could not only
evaluate the exact status of engraftment but also assist in
deciding the treatment modalities. In the present study, we
analyzed the use of 11 polymorphic STR/VNTR markers in
randomly selected north Indian individuals and HLA-
matched donor–recipient pairs to identify a highly in-
formative and successful STR/VNTR panel for chimerism
studies. We identified a set of seven markers (ApoB3HVR,
D3S1358, VWF1, FES, VWA, Tho1 and D16S310), which
differentiated 98.70% of the 77 HLA matched donor–
recipient pairs and successfully monitored the status of
engraftment in 14 cases at different time points following
HSCT. These results have major implications considering
the significant rise in the HSCT performed within India
during the last decade. The importance increases as
clinicians consider non-myeloablative transplantation14
and T-cell depletion HSCT or peripheral blood stem cell
transplantation (PBSCT) instead of the traditional HSCT
approach (myeloablative HSCT). In such cases, chimerism
monitoring is a prerequisite for manipulating engraftment
by altering patient immunosuppression and donor’s lym-
phocyte infusion.10,14
Both random population and donor–recipient pair
analysis was considered necessary to identify an informa-
tive set of marker before assessing its success in chimerism
monitoring. This tripartite analysis aided in developing a
robust scheme and a reliable method of chimerism
evaluation, which could be effective for a large set of
populations irrespective of the genetic or socio-cultural
heterogeneity existing between sects and sub-groups. In the
first phase of analysis, we genotyped 11 markers in 1000
randomly selected north Indian subjects and identified a
high range of allelic variability. A total of 111 observed
alleles with as many as 16 alleles were observed at
Table 2 Informativity values of individual and group of STR/VNTR markers among 77 HSCT donor–recipient pairs
Average % informativity
Single locusa
Apo FES VWF1 TPO VWA Tho1 D4S D3S F13 D16 DHF
54.0 56.0 52.0 43.0 50.0 51.0 32.0 48.0 49.0 51.0 36.0
Three locus
APO-FES-VWF1 D4S-F13-TPO Tho1-TPO-F13-TPO D3S, D16, DHFRP2
92.2 83.1 81.1 79.2
Five locusa
APO-FES-D3S-VWA-D16 APO-FES-D4S-Tho1-F13 APO-TPO-D4S-FES-DHF
96.1 93.5 92.2
Seven locusa
APO-D3S-vWF1-FES-VWA-Tho1-D16 APO-D4S-TPO-VWA-FES-F13-VWF1 APO-Tho1-TPO-F13-D16-DHF-D4S
98.7 96.5 95.4
Abbreviations: HSCT¼ hematopoietic stem cell transplantation; STR/VNTR¼ short tandem repeats/variable number tandem repeats.
aApo¼ApoB30HVR; D4S¼D4S243; D3S¼D3S1358; F13¼F13A; D16¼D16S310; DHF¼DHFRP2.
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ApoB30HVR, which is in accordance with other studies.15
STR and VNTR markers are the most accepted regions of
the human genome for assessing the levels of genetic
diversity owing to their high mutation rates and high degree
of polymorphism.16 We also calculated different diversity
parameters in order to quantify the range of polymorphism
and genetic diversity. The analysis helped in categorizing an
individual marker or set of markers that would have
maximum individual identification potential. The majority
of STR loci are known to possess a heterozygosity level of
more than 60%,16 possibly accounting for their success in
chimerism monitoring. The average observed heterozygo-
sity was found to be 0.75670.17 confirming the findings of
other studies based on different Indian populations.17–18
Other parameters (PIC and PE) also indicated a relatively
equal distribution of large number of alleles and an
optimistic potential for success in chimerism monitoring.
The random population analysis determined that individu-
ally ApoB30HVR, D3S1358, FES, VWA and D16S310
possess maximum variability and chimerism evaluation
potential.
Markers with high informativeness for chimerism studies
were selected from the second step of analysis carried out in
77 HLA-matched donor–recipient pairs. Three markers,
FES, ApoB30HVR and D3S1358 were found to be most
informative. The findings corroborated the population
study results; however, the individual locus differentiated
only up to 56% of donors and recipients pairs. Interest-
ingly, two more loci VWF1 and Tho1 also exhibited
high informativeness despite depicting less diversity in
the random population analysis. Sellathamby et al.,11 in
their work on 310 recipient-donor pair, has also shown
that Tho1 and VWF1 exhibited an informativeness of
B54%. The informativeness percentage of different
marker groups was calculated based on the informativeness
of each locus. A set of seven markers (ApoB3HVR,
D3S1358, VWF1, FES, VWA, Tho1 and D16S310) was
found most informative with total informativeness being
98.70%. Recently, Thiede et al.19 have calculated the
informativeness of 27 STR markers in 203 matched related
donor–recipient pairs and found Penta E and SE33
(ACTBP2) to be highly informative. Similarly, Hassan
et al.20 studied eight STR/VNTR markers in a patient/
donor cohort (n¼ 195) and found that at least one
informative marker was detected in 177 pairs (91%).
Sellathamby et al.11 attempted to develop an algorithm
Tho1 
D16S310 
F13A
TPO
D3S1358 
DHFRP2 
vWA 
vWF1 
ApoB3 HVR 
D4S243 
FES
I=32.0% 
I= 43.0% 
I=56.0% 
I=49.0% 
I=50.0% 
I=48.0% 
I=54.0% 
I=51.0% 
I=52.0% 
I=51.0% 
I=36.0% 
ApoB3HVR 
FES
vWF1 
ApoB3HVR 
FES
vWF1 
vWA 
D16S310 
D3S1358 
ApoB3HVR 
FES
vWF1 
vWA 
D16S310 
D3S1358 
Tho1 
I=92.2% 
I=96.1% 
I=98.70%
,
Figure 1 Algorithm of seven STR/VNTR for chimerism evaluation.
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based on the analysis of five markers. They reported
the combined informativeness of 95% in a cohort of
310 patient–donor pair. Our attempt to develop such
an algorithm (Figure 1) was based on the cumulative
results obtained from the three-level analysis of both
random north Indian population and HLA-matched
donor–recipient pairs. This approach magnified the prob-
ability of the identified STR/VNTR panel to be more
successful for larger set of populations. The population
study identified ApoB30HVR, D3S1358, FES, VWA and
D16S310 as the most valuable markers based on different
diversity parameters whereas patient–donor pair analysis
identified Tho1 and VWF1 as other two compelling
markers based on their high informativeness index. Finally,
the panel of seven STR was 100% successful in differ-
entiating donors cells from that of recipient at all the stages
after engraftment. Three chimerism stages: complete
chimerism (only donor’s cells), mixed chimerism (both
donor’s and recipient’s cells) and no chimerism or relapse
of the disease (only recipient’s cell) were identified with
100% accuracy.
In order to evaluate the cost-effectiveness of the panel of
seven markers in graft monitoring, the results were
compared from the 14 HSCT cases using SGM plus
multiplex PCR kit. Our findings indicated that SGM
plus PCR kit was informative in 11 HSCT cases
(78.5%) in comparison with the 100% informativeness of
our panel. The fragment size calling was 499% accurate
and precise with both the SGM kit and our panel
of markers. Additionally, the cost of analysis of seven
markers as multiplex system (two PCR and one
electrophoresis run using 1000 ROX as size standard)
was less than $5 per sample using ABI 310 genetic
analyzer. Moreover, we also successfully genotyped all
seven markers by separating the amplicons of each locus
individually using 10% PAGE followed by the silver
staining. This would provide an option of manual
allele scoring in labs where an automated fragment size
analyzer is not available.
In conclusion, the identification of the panel of seven
markers based on the chimerism evaluation algorithm
developed in the present study can be a useful, practical
and reliable tool for chimerism monitoring following
allogeneic HSCT.
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